Cite
MLA Citation
V. Santini et al.. “Impact of Gene Mutations on Response to Lenalidomide and OS in Lower-Risk Non-Del(5Q) MDS Patients Ineligible/Refractory to Erythropoiesis-Stimulating Agents (ESAS).” Leukemia research, vol. 55, n.d., pp. S14–. http://access.bl.uk/ark:/81055/vdc_100045920464.0x000059